Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 49 entries
Sorted by: Best Match Show Resources per page
Correction to: Significance and Role of Pattern Recognition Receptors in Malignancy.

Archivum immunologiae et therapiae experimentalis

Żeromski J, Kaczmarek M, Boruczkowski M, Kierepa A, Kowala-Piaskowska A, Mozer-Lisewska I.
PMID: 31473789
Arch Immunol Ther Exp (Warsz). 2019 Oct;67(5):351. doi: 10.1007/s00005-019-00557-2.

The authors would like to correct the following error.

Cite
Żeromski J, Kaczmarek M, Boruczkowski M, et al. Correction to: Significance and Role of Pattern Recognition Receptors in Malignancy. Arch Immunol Ther Exp (Warsz). 2019;67(5):351doi: 10.1007/s00005-019-00557-2.
Żeromski, J., Kaczmarek, M., Boruczkowski, M., Kierepa, A., Kowala-Piaskowska, A., & Mozer-Lisewska, I. (2019). Correction to: Significance and Role of Pattern Recognition Receptors in Malignancy. Archivum immunologiae et therapiae experimentalis, 67(5), 351. https://doi.org/10.1007/s00005-019-00557-2
Żeromski, Jan, et al. "Correction to: Significance and Role of Pattern Recognition Receptors in Malignancy." Archivum immunologiae et therapiae experimentalis vol. 67,5 (2019): 351. doi: https://doi.org/10.1007/s00005-019-00557-2
Żeromski J, Kaczmarek M, Boruczkowski M, Kierepa A, Kowala-Piaskowska A, Mozer-Lisewska I. Correction to: Significance and Role of Pattern Recognition Receptors in Malignancy. Arch Immunol Ther Exp (Warsz). 2019 Oct;67(5):351. doi: 10.1007/s00005-019-00557-2. PMID: 31473789; PMCID: PMC6732119.
Copy Download .nbib Format: NLM
Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis.

Archivum immunologiae et therapiae experimentalis

Kasarełło K, Snarski E, Sulejczak D, Ciesielski T, Wiśniewska A, Wrzesień R, Cudnoch-Jędrzejewska A.
PMID: 34181099
Arch Immunol Ther Exp (Warsz). 2021 Jun 28;69(1):17. doi: 10.1007/s00005-021-00619-4.

Experimental allergic encephalomyelitis (EAE) is the animal model of multiple sclerosis (MS). Autologous hematopoietic stem cell transplantation (AHSCT) has recently been recognized as the standard treatment for MS. The aim of our experiment was to investigate the effect of...

Cite
Kasarełło K, Snarski E, Sulejczak D, et al. Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis. Arch Immunol Ther Exp (Warsz). 2021;69(1):17doi: 10.1007/s00005-021-00619-4.
Kasarełło, K., Snarski, E., Sulejczak, D., Ciesielski, T., Wiśniewska, A., Wrzesień, R., & Cudnoch-Jędrzejewska, A. (2021). Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis. Archivum immunologiae et therapiae experimentalis, 69(1), 17. https://doi.org/10.1007/s00005-021-00619-4
Kasarełło, Kaja, et al. "Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis." Archivum immunologiae et therapiae experimentalis vol. 69,1 (2021): 17. doi: https://doi.org/10.1007/s00005-021-00619-4
Kasarełło K, Snarski E, Sulejczak D, Ciesielski T, Wiśniewska A, Wrzesień R, Cudnoch-Jędrzejewska A. Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis. Arch Immunol Ther Exp (Warsz). 2021 Jun 28;69(1):17. doi: 10.1007/s00005-021-00619-4. PMID: 34181099; PMCID: PMC8238731.
Copy Download .nbib Format: NLM
Stimulation of Innate and Adaptive Immune Cells with Graphene Oxide and Reduced Graphene Oxide Affect Cancer Progression.

Archivum immunologiae et therapiae experimentalis

Yunus MA, Ramli MM, Osman NH, Mohamed R.
PMID: 34327598
Arch Immunol Ther Exp (Warsz). 2021 Jul 29;69(1):20. doi: 10.1007/s00005-021-00625-6.

Sole nanomaterials or nanomaterials bound to specific biomolecules have been proposed to regulate the immune system. These materials have now emerged as new tools for eliciting immune-based therapies to treat various cancers. Graphene, graphene oxide (GO) and reduced GO...

Cite
Yunus MA, Ramli MM, Osman NH, et al. Stimulation of Innate and Adaptive Immune Cells with Graphene Oxide and Reduced Graphene Oxide Affect Cancer Progression. Arch Immunol Ther Exp (Warsz). 2021;69(1):20doi: 10.1007/s00005-021-00625-6.
Yunus, M. A., Ramli, M. M., Osman, N. H., & Mohamed, R. (2021). Stimulation of Innate and Adaptive Immune Cells with Graphene Oxide and Reduced Graphene Oxide Affect Cancer Progression. Archivum immunologiae et therapiae experimentalis, 69(1), 20. https://doi.org/10.1007/s00005-021-00625-6
Yunus, Muhammad Amir, et al. "Stimulation of Innate and Adaptive Immune Cells with Graphene Oxide and Reduced Graphene Oxide Affect Cancer Progression." Archivum immunologiae et therapiae experimentalis vol. 69,1 (2021): 20. doi: https://doi.org/10.1007/s00005-021-00625-6
Yunus MA, Ramli MM, Osman NH, Mohamed R. Stimulation of Innate and Adaptive Immune Cells with Graphene Oxide and Reduced Graphene Oxide Affect Cancer Progression. Arch Immunol Ther Exp (Warsz). 2021 Jul 29;69(1):20. doi: 10.1007/s00005-021-00625-6. PMID: 34327598.
Copy Download .nbib Format: NLM
Should Nano-Particles be Weighed or Counted? Technical Considerations to In Vitro Testing Originated from Corpuscular Nature of Nano-Particles.

Archivum immunologiae et therapiae experimentalis

Kałas W.
PMID: 34345944
Arch Immunol Ther Exp (Warsz). 2021 Aug 03;69(1):23. doi: 10.1007/s00005-021-00623-8.

The abundance of nanoparticles introduced to household products created the great expectations towards the application of nanotechnology in biology and medicine. That calls for cost-effective preliminary assessment of its cytotoxicity and biological activity. There are many attempts for creating...

Cite
Kałas W. Should Nano-Particles be Weighed or Counted? Technical Considerations to In Vitro Testing Originated from Corpuscular Nature of Nano-Particles. Arch Immunol Ther Exp (Warsz). 2021;69(1):23doi: 10.1007/s00005-021-00623-8.
Kałas, W. (2021). Should Nano-Particles be Weighed or Counted? Technical Considerations to In Vitro Testing Originated from Corpuscular Nature of Nano-Particles. Archivum immunologiae et therapiae experimentalis, 69(1), 23. https://doi.org/10.1007/s00005-021-00623-8
Kałas, Wojciech. "Should Nano-Particles be Weighed or Counted? Technical Considerations to In Vitro Testing Originated from Corpuscular Nature of Nano-Particles." Archivum immunologiae et therapiae experimentalis vol. 69,1 (2021): 23. doi: https://doi.org/10.1007/s00005-021-00623-8
Kałas W. Should Nano-Particles be Weighed or Counted? Technical Considerations to In Vitro Testing Originated from Corpuscular Nature of Nano-Particles. Arch Immunol Ther Exp (Warsz). 2021 Aug 03;69(1):23. doi: 10.1007/s00005-021-00623-8. PMID: 34345944; PMCID: PMC8332567.
Copy Download .nbib Format: NLM
[Present concepts on the nature of leukoses].

Archivum immunologiae et therapiae experimentalis

RAUSHENBAKH MO.
PMID: 13395843
Arch Immunol Ther Exp (Warsz). 1955;3:463-79.

No abstract available.

Cite
RAUSHENBAKH MO. Sovremennye predstavleniia o prirode leikozov. [Present concepts on the nature of leukoses]. Arch Immunol Ther Exp (Warsz). 1955;3:463-79
RAUSHENBAKH, M. O. (1955). Sovremennye predstavleniia o prirode leikozov. [Present concepts on the nature of leukoses]. Archivum immunologiae et therapiae experimentalis, 3463-79.
RAUSHENBAKH, M O. "Sovremennye predstavleniia o prirode leikozov." [Present concepts on the nature of leukoses]. Archivum immunologiae et therapiae experimentalis vol. 3 (1955): 463-79.
RAUSHENBAKH MO. Sovremennye predstavleniia o prirode leikozov. [Present concepts on the nature of leukoses]. Arch Immunol Ther Exp (Warsz). 1955;3:463-79. Russian. PMID: 13395843.
Copy Download .nbib Format: NLM
Erratum to: Pro-Cognitive Properties of the Immunomodulatory Polypeptide Complex, Yolkin, from Chicken Egg Yolk and Colostrum-Derived Substances: Analyses Based on Animal Model of Age-Related Cognitive Deficits.

Archivum immunologiae et therapiae experimentalis

Lemieszewska M, Jakubik-Witkowska M, Stańczykiewicz B, Zambrowicz A, Zabłocka A, Polanowski A, Trziszka T, Rymaszewska J.
PMID: 27160207
Arch Immunol Ther Exp (Warsz). 2017 Feb;65(1):99. doi: 10.1007/s00005-016-0398-6.

No abstract available.

Cite
Lemieszewska M, Jakubik-Witkowska M, Stańczykiewicz B, et al. Erratum to: Pro-Cognitive Properties of the Immunomodulatory Polypeptide Complex, Yolkin, from Chicken Egg Yolk and Colostrum-Derived Substances: Analyses Based on Animal Model of Age-Related Cognitive Deficits. Arch Immunol Ther Exp (Warsz). 2017;65(1):99doi: 10.1007/s00005-016-0398-6.
Lemieszewska, M., Jakubik-Witkowska, M., Stańczykiewicz, B., Zambrowicz, A., Zabłocka, A., Polanowski, A., Trziszka, T., & Rymaszewska, J. (2017). Erratum to: Pro-Cognitive Properties of the Immunomodulatory Polypeptide Complex, Yolkin, from Chicken Egg Yolk and Colostrum-Derived Substances: Analyses Based on Animal Model of Age-Related Cognitive Deficits. Archivum immunologiae et therapiae experimentalis, 65(1), 99. https://doi.org/10.1007/s00005-016-0398-6
Lemieszewska, Marta, et al. "Erratum to: Pro-Cognitive Properties of the Immunomodulatory Polypeptide Complex, Yolkin, from Chicken Egg Yolk and Colostrum-Derived Substances: Analyses Based on Animal Model of Age-Related Cognitive Deficits." Archivum immunologiae et therapiae experimentalis vol. 65,1 (2017): 99. doi: https://doi.org/10.1007/s00005-016-0398-6
Lemieszewska M, Jakubik-Witkowska M, Stańczykiewicz B, Zambrowicz A, Zabłocka A, Polanowski A, Trziszka T, Rymaszewska J. Erratum to: Pro-Cognitive Properties of the Immunomodulatory Polypeptide Complex, Yolkin, from Chicken Egg Yolk and Colostrum-Derived Substances: Analyses Based on Animal Model of Age-Related Cognitive Deficits. Arch Immunol Ther Exp (Warsz). 2017 Feb;65(1):99. doi: 10.1007/s00005-016-0398-6. PMID: 27160207; PMCID: PMC6828119.
Copy Download .nbib Format: NLM
On the fairness of using relative indicators for comparing citation performance in different disciplines.

Archivum immunologiae et therapiae experimentalis

Castellano C, Radicchi F.
PMID: 19333733
Arch Immunol Ther Exp (Warsz). 2009 Mar-Apr;57(2):85-90. doi: 10.1007/s00005-009-0014-0. Epub 2009 Mar 31.

Relative indicators are commonly used to remove biases due to different citation practices in various scientific fields. Here we extend our recent investigation on the viability of the use of relative indicators for comparing article impact in different disciplines....

Cite
Castellano C, Radicchi F. On the fairness of using relative indicators for comparing citation performance in different disciplines. Arch Immunol Ther Exp (Warsz). 2009;57(2):85-90doi: 10.1007/s00005-009-0014-0.
Castellano, C., & Radicchi, F. (2009). On the fairness of using relative indicators for comparing citation performance in different disciplines. Archivum immunologiae et therapiae experimentalis, 57(2), 85-90. https://doi.org/10.1007/s00005-009-0014-0
Castellano, Claudio, and Radicchi, Filippo. "On the fairness of using relative indicators for comparing citation performance in different disciplines." Archivum immunologiae et therapiae experimentalis vol. 57,2 (2009): 85-90. doi: https://doi.org/10.1007/s00005-009-0014-0
Castellano C, Radicchi F. On the fairness of using relative indicators for comparing citation performance in different disciplines. Arch Immunol Ther Exp (Warsz). 2009 Mar-Apr;57(2):85-90. doi: 10.1007/s00005-009-0014-0. Epub 2009 Mar 31. PMID: 19333733.
Copy Download .nbib Format: NLM
[Ganglionic action of heterocyclic pendiomide derivatives].

Archivum immunologiae et therapiae experimentalis

WILIMOWSKI M, DJACZYSZYN H, GIELDANOWSKI J.
PMID: 13488716
Arch Immunol Ther Exp (Warsz). 1956;4:391-8.

No abstract available.

Cite
WILIMOWSKI M, DJACZYSZYN H, GIELDANOWSKI J. Działlanie zwojowe heterocyklicznych pochodnych pendiomidu. [Ganglionic action of heterocyclic pendiomide derivatives]. Arch Immunol Ther Exp (Warsz). 1956;4:391-8
WILIMOWSKI, M., DJACZYSZYN, H., & GIELDANOWSKI, J. (1956). Działlanie zwojowe heterocyklicznych pochodnych pendiomidu. [Ganglionic action of heterocyclic pendiomide derivatives]. Archivum immunologiae et therapiae experimentalis, 4391-8.
WILIMOWSKI, M, et al. "Działlanie zwojowe heterocyklicznych pochodnych pendiomidu." [Ganglionic action of heterocyclic pendiomide derivatives]. Archivum immunologiae et therapiae experimentalis vol. 4 (1956): 391-8.
WILIMOWSKI M, DJACZYSZYN H, GIELDANOWSKI J. Działlanie zwojowe heterocyklicznych pochodnych pendiomidu. [Ganglionic action of heterocyclic pendiomide derivatives]. Arch Immunol Ther Exp (Warsz). 1956;4:391-8. Polish. PMID: 13488716.
Copy Download .nbib Format: NLM
Neoantigen Cancer Vaccines: Real Opportunity or Another Illusion?.

Archivum immunologiae et therapiae experimentalis

Manoutcharian K, Guzman Valle J, Gevorkian G.
PMID: 33909124
Arch Immunol Ther Exp (Warsz). 2021 Apr 28;69(1):12. doi: 10.1007/s00005-021-00615-8.

In this communication, we will analyze some important factors and immunological phenomena related to neoantigen cancer vaccines, with particular emphasis on recently published Phase I clinical trials. Several obstacles and issues are addressed that challenge the current paradigm and...

Cite
Manoutcharian K, Guzman Valle J, Gevorkian G. Neoantigen Cancer Vaccines: Real Opportunity or Another Illusion?. Arch Immunol Ther Exp (Warsz). 2021;69(1):12doi: 10.1007/s00005-021-00615-8.
Manoutcharian, K., Guzman Valle, J., & Gevorkian, G. (2021). Neoantigen Cancer Vaccines: Real Opportunity or Another Illusion?. Archivum immunologiae et therapiae experimentalis, 69(1), 12. https://doi.org/10.1007/s00005-021-00615-8
Manoutcharian, Karen, et al. "Neoantigen Cancer Vaccines: Real Opportunity or Another Illusion?." Archivum immunologiae et therapiae experimentalis vol. 69,1 (2021): 12. doi: https://doi.org/10.1007/s00005-021-00615-8
Manoutcharian K, Guzman Valle J, Gevorkian G. Neoantigen Cancer Vaccines: Real Opportunity or Another Illusion?. Arch Immunol Ther Exp (Warsz). 2021 Apr 28;69(1):12. doi: 10.1007/s00005-021-00615-8. PMID: 33909124; PMCID: PMC8080209.
Copy Download .nbib Format: NLM
Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies.

Archivum immunologiae et therapiae experimentalis

Mazza R, Maher J.
PMID: 34897554
Arch Immunol Ther Exp (Warsz). 2021 Dec 12;70(1):2. doi: 10.1007/s00005-021-00640-7.

Technologies required to generate induced pluripotent stem cells (iPSC) were first described 15 years ago, providing a strong impetus to the field of regenerative medicine. In parallel, immunotherapy has finally emerged as a clinically meaningful modality of cancer therapy....

Cite
Mazza R, Maher J. Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies. Arch Immunol Ther Exp (Warsz). 2021;70(1):2doi: 10.1007/s00005-021-00640-7.
Mazza, R., & Maher, J. (2021). Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies. Archivum immunologiae et therapiae experimentalis, 70(1), 2. https://doi.org/10.1007/s00005-021-00640-7
Mazza, Roberta, and Maher, John. "Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies." Archivum immunologiae et therapiae experimentalis vol. 70,1 (2021): 2. doi: https://doi.org/10.1007/s00005-021-00640-7
Mazza R, Maher J. Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies. Arch Immunol Ther Exp (Warsz). 2021 Dec 12;70(1):2. doi: 10.1007/s00005-021-00640-7. PMID: 34897554.
Copy Download .nbib Format: NLM
Osteopontin and Transplantation: Where Are We Now?.

Archivum immunologiae et therapiae experimentalis

Kaleta B.
PMID: 34019147
Arch Immunol Ther Exp (Warsz). 2021 May 21;69(1):15. doi: 10.1007/s00005-021-00617-6.

Organ transplantation represents the optimal therapeutic tool for patients with end-stage organ failure. Hematopoietic stem cell transplantation (HSCT) is likewise an effective therapy for a wide range of malignant and non-malignant diseases. Better understanding of transplantation immunology and the...

Cite
Kaleta B. Osteopontin and Transplantation: Where Are We Now?. Arch Immunol Ther Exp (Warsz). 2021;69(1):15doi: 10.1007/s00005-021-00617-6.
Kaleta, B. (2021). Osteopontin and Transplantation: Where Are We Now?. Archivum immunologiae et therapiae experimentalis, 69(1), 15. https://doi.org/10.1007/s00005-021-00617-6
Kaleta, Beata. "Osteopontin and Transplantation: Where Are We Now?." Archivum immunologiae et therapiae experimentalis vol. 69,1 (2021): 15. doi: https://doi.org/10.1007/s00005-021-00617-6
Kaleta B. Osteopontin and Transplantation: Where Are We Now?. Arch Immunol Ther Exp (Warsz). 2021 May 21;69(1):15. doi: 10.1007/s00005-021-00617-6. PMID: 34019147; PMCID: PMC8139897.
Copy Download .nbib Format: NLM
Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition.

Archivum immunologiae et therapiae experimentalis

Siri M, Behrouj H, Dastghaib S, Zamani M, Likus W, Rezaie S, Hudecki J, Khazayel S, Łos MJ, Mokarram P, Ghavami S.
PMID: 34536148
Arch Immunol Ther Exp (Warsz). 2021 Sep 18;69(1):26. doi: 10.1007/s00005-021-00629-2.

Adjuvant chemotherapy with 5-fluorouracil (5-FU) does not improve survival of patients suffering from a form of colorectal cancer (CRC) characterized by high level of microsatellite instability (MSI-H). Given the importance of autophagy and multi-drug-resistant (MDR) proteins in chemotherapy resistance,...

Cite
Siri M, Behrouj H, Dastghaib S, et al. Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition. Arch Immunol Ther Exp (Warsz). 2021;69(1):26doi: 10.1007/s00005-021-00629-2.
Siri, M., Behrouj, H., Dastghaib, S., Zamani, M., Likus, W., Rezaie, S., Hudecki, J., Khazayel, S., Łos, M. J., Mokarram, P., & Ghavami, S. (2021). Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition. Archivum immunologiae et therapiae experimentalis, 69(1), 26. https://doi.org/10.1007/s00005-021-00629-2
Siri, Morvarid, et al. "Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition." Archivum immunologiae et therapiae experimentalis vol. 69,1 (2021): 26. doi: https://doi.org/10.1007/s00005-021-00629-2
Siri M, Behrouj H, Dastghaib S, Zamani M, Likus W, Rezaie S, Hudecki J, Khazayel S, Łos MJ, Mokarram P, Ghavami S. Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition. Arch Immunol Ther Exp (Warsz). 2021 Sep 18;69(1):26. doi: 10.1007/s00005-021-00629-2. PMID: 34536148; PMCID: PMC8449776.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 49 entries